SIGN INMYPAGE

The Liver Week 2024

  • INTRODUCTION
    • Welcome
    • Organization
    • Information
    • History
  • PROGRAM
    • Program at a Glance
    • Daily Program
    • Invited Faculty
    • Food & Beverage
    • Industry Symposia
  • ABSTRACT
    • Submission Guidelines
    • Presentation Guidelines
    • Award Program
  • REGISTRATION
    • Registration
    • 평점안내
  • VENUE
    • Venue
    • Accommodation
    • Transportation
    • Seoul
  • PARTNERSHIP
    • Partnership

PROGRAMThe Liver Week 2024Towards Precision Medicine in Practice and Research of HepatologyJune 27-29, 2024lWalkerhill, Seoul, Korea

PROGRAM AT A GLANCE DAILY PROGRAM INVITED FACULTY MEAL PLAN INDUSTRY SYMPOSIA

Program Download

  • Thursday, June 27, 2024
  • Friday, June 28, 2024
  • Saturday, June 29, 2024
  • VISTA I+II ROOM 1
  • VISTA III ROOM 2
  • WALKER I ROOM 3
  • WALKER II ROOM 4
  • GRAND IV ROOM 5

  • GRAND V ROOM 6
  • GRAND VI ROOM 7
  • ART HALL ROOM 8

09:10-10:30

KASL Symposium 4
Portal Hypertension and Its Repercussions in Hepatic Care

Chair: Chang Wook Kim (The Catholic Univ. of Korea), Jongman Kim (Sungkyunkwan Univ.)

  • 09:10-09:30

  • Personalized Approach to Albumin Replacement in Decompensated Cirrhosis

    Rakhi Maiwall (Institute of Liver and Biliary Sciences, India)

  • 09:30-09:50

  • Correction and Prevention of Hyponatremia in Cirrhotic Patients with Ascites

    Sejoong Kim (Seoul National Univ.)

  • 09:50-10:10

  • Diagnostic Test and Available Therapy for Covert vs. Overt Hepatic Encephalopathy

    Elliot B. Tapper (Univ. of Michigan, USA)

  • 10:10-10:30

  • Blood Products and Pharmacologic Agents and Their Indications for Hepatic Coagulopathy

    Eileen L. Yoon (Hanyang Univ.)

  • 10:30-10:50

  • Coffee Break

10:50-11:20

State-of-the-Art Lecture

Chair: Joo Hyun Sohn (Hanyang Univ.)

  • 10:50-11:20

  • Advances in Non-Invasive Assessment of MASH

    Rohit Loomba (Univ. of California San Diego, USA)

11:20-12:20

Plenary Presentation 2

Chair: Jin Sub Choi (Yonsei Univ.), Hee Chul Yu (Jeonbuk National Univ.), Hyung Joon Yim (Korea Univ.)

  • 11:20-11:35

  • [PP2-1] Merlin-TAZ Pathway by miR-4449 Regulates Fibrosis Progression in MASH

    Eunho Choi (Korea Univ.)

  • 11:35-11:50

  • [PP2-2] Cardiovascular Risk from Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Risk Factor Count, and Their Longitudinal Changes

    Han Ah Lee (Chung-Ang Univ.)

  • 11:50-12:05

  • [PP2-3] AI-Assisted Intraoperative Navigation for Safe Right Liver Mobilization during Pure Laparoscopic Donor Right Hepatectomy

    Namkee Oh (Sungkyunkwan Univ.)

  • 12:05-12:20

  • [PP2-4] EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization (TACE) Combined with Durvalumab (D) with or without Bevacizumab (B) in Participants with Unresectable Hepatocellular Carcinoma (uHCC) Eligible for Embolization

    Jeong Heo (Pusan National Univ.)

  • 12:20-13:10

  • Luncheon Symposium 7 [Yuhan]

13:10-13:40

President's Choice Lecture

Chair: Yoon Jun Kim (Seoul National Univ.)

  • 13:10-13:40

  • Innovative Immunotherapy Concepts for Liver Cancer

    Tim F. Greten (National Cancer Institute, USA)

13:40-15:00

KASL Symposium 5
Personalized Approaches to Liver Disease

Chair: Byung-Cheol Song (Jeju National Univ.), Mark Muthiah (National Univ. Hospital, Singapore)

  • 13:40-14:00

  • Effectiveness and Challenges of Etiology-Based Surveillance Approaches for HCC

    Won Sohn (Sungkyunkwan Univ.)

  • 14:00-14:20

  • Virologic and Immunologic Biomarkers to Guide Treatment of Chronic Hepatitis B

    Wai-Kay Seto (The Univ. of Hong Kong, Hong Kong)

  • 14:20-14:40

  • Role of Combination Therapy in Hepatic Encephalopathy

    Barjesh Chander Sharma (Govind Ballabh Pant Hospital, India)

  • 14:40-15:00

  • Molecular-Based Strategy for Atezo/Bev-Failed HCC: The 2025 French Medicine Genomic Program

    Jean-Charles Nault (Sorbonne Université, France)

  • 15:00-15:20

  • Coffee Break

15:20-16:20

The Liver Week 2024 Debrief Session

Chair: Ju Hyun Shim (KASL), Jongman Kim (KAHBPS), Su Jong Yu (KLCA), Hae Won Lee (KLTS)

  • 15:20-15:35

  • KASL

    Moon Haeng Hur (Seoul National Univ.)

  • 15:35-15:50

  • KAHBPS

    Jinsoo Rhu (Sungkyunkwan Univ.)

  • 15:50-16:05

  • KLCA

    Hye Won Lee (Yonsei Univ.)

  • 16:05-16:20

  • KLTS

    Jae Geun Lee (Yonsei Univ.)

  • 16:20-16:40

  • Closing & Award Ceremony

08:00-09:00

KASL-AASLD Morning Workshop
Impact of Early TIPS for the Management of Variceal Bleeding

Chair & Panel: Grace L. Su (Univ. of Michigan, USA), June Sung Lee (Inje Univ.)

  • 08:00-08:15

  • Case and Topic Presentation

    Eun Sun Jang (Seoul National Univ.)

  • 08:15-08:30

  • Better

    Guadalupe Garcia-Tsao (Yale Univ., USA)

  • 08:30-08:45

  • Worse

    Yeon Seok Seo (Korea Univ.)

  • 08:45-09:00

  • Panel Discussion
    2 Speakers & 2 Panelists

09:10-10:30

KLCA-TLCA Joint Symposium
East Meets Excellence: Exploring HCC Guidelines of Korea and Taiwan

Chair: Jong Young Choi (The Catholic Univ. of Korea), Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan)

  • 09:10-09:25

  • Biomarkers-Guided Liver Transplantation for Advanced HCC in Korea

    YoungRok Choi (Seoul National Univ.)

  • 09:25-09:40

  • AI Research of HCC in Taiwan

    Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan)

  • 09:40-09:55

  • Dissecting the Divergence: A Comparative Analysis of Stage-Specific HCC Treatment Approaches in Korea

    Ji Hoon Kim (Korea Univ.)

  • 09:55-10:10

  • Dissecting the Divergence: A Comparative Analysis of Stage-Specific HCC Treatment Approaches in Taiwan

    I-Cheng Lee (National Yang Ming Chiao Tung Univ., Taiwan)

  • 10:10-10:30

  • Discussion

  • 10:30-10:50

  • Coffee Break

  • 10:50-12:20

  • State-of-the-Art Lecture / Plenary Presentation 2 [* VISTA I+II]

  • 12:20-13:10

  • Luncheon Symposium 8 [Eisai]

  • 13:10-13:40

  • President's Choice Lecture [* VISTA I+II]

13:40-15:00

KLCA-KASL Joint Symposium
We Are Not Alone: Pioneering Combinational Approaches in HCC

Chair: Kyung Sik Kim (Yonsei Univ.), Han Chu Lee (Univ. of Ulsan)

  • 13:40-14:00

  • Maximizing Early-Stage HCC Outcomes through Neoadjuvant and Adjuvant Strategies

    Andrea Casadei Gardini (Univ. Vita-Salute San Raffaele, Italy)

  • 14:00-14:20

  • Integrating Loco-Regional and Systemic Therapies for Holistic Care in Intermediate-Stage HCC

    Jin Woo Choi (Seoul National Univ.)

  • 14:20-14:40

  • The Synergistic Role of Radiotherapy in Multimodal HCC Management

    Sang Min Yoon (Univ. of Ulsan)

  • 14:40-15:00

  • Navigating Future Prospects for Triple Systemic Therapies in HCC

    Richard S. Finn (Univ. of California Los Angeles, USA)

09:10-10:30

Special Symposium 2
The MASH-HCC Nexus: From Epidemiology to Clinical Outcomes

Chair: Jung-Hwan Yoon (Seoul National Univ.), Pierce Chow (National Cancer Centre Singapore, Singapore)

  • 09:10-09:30

  • Changing HCC Epidemiology: Shifting from Non-MASH to MASH-HCC

    Jeong-Ju Yoo (Soonchunhyang Univ.)

  • 09:30-09:50

  • Immune and Molecular Pathophysiology of MASH-HCC

    Tim F. Greten (National Cancer Institute, USA)

  • 09:50-10:10

  • Strategies for Surveillance and Diagnosis in MASH-HCC

    Bo Hyun Kim (National Cancer Center)

  • 10:10-10:30

  • The Future Landscape of Personalized Medicine for Immunotherapies in MASH-HCC

    Yun Bin Lee (Seoul National Univ.)

  • 12:20-13:10

  • Luncheon Symposium 9 [Samil]

13:40-15:00

Special Symposium 3
Predictive Analytics and Risk Assessment

Chair: Won Young Tak (Kyungpook National Univ.), Moon Seok Choi (Sungkyunkwan Univ.)

  • 13:40-14:00

  • Statistical Strategies and Common Pitfalls for Risk Calculators

    Sangwook Kang (Yonsei Univ.)

  • 14:00-14:20

  • The Evolution and Implications of MELD Score: Version 3.0

    W. Ray Kim (Stanford Univ., USA)

  • 14:20-14:40

  • Analytic Morphomics for Predicting Outcomes of Liver Disease

    Grace L. Su (Univ. of Michigan, USA)

  • 14:40-15:00

  • HCC Prediction Models Specific to Underlying Liver Disease

    Minjong Lee (Ewha Womans Univ.)

08:00-09:00

KAHBPS Symposium 1
Technical Advances in Minimally Invasive Liver Surgery

Chair: Young Seok Han (Dague Catholic Univ.), Hae Won Lee (Seoul National Univ.)

  • 08:00-08:15

  • Considerations and Outcomes in Robotic Hepatectomy for Anatomically Challenging Hepatic Tumors

    Nuri Lee (Veterans Health Care Medical Center)

  • 08:15-08:30

  • Hepatic Vein-Guided Anatomical Liver Resection

    Wipusit Taesombat (Chulalongkorn Univ., Thailand)

  • 08:30-08:45

  • Pre-Reconstructed 3D Images Using AI Model for Liver Resection

    Jinsoo Rhu (Sungkyunkwan Univ.)

  • 08:45-09:00

  • Overcoming Difficult Anatomical Variations of Minimal Invasive Donor Hepatectomy

    Ho Joong Choi (The Catholic Univ. of Korea)

09:10-10:30

KAHBPS Symposium 2
Biliary Pancreatic Disease in Cirrhotic Patients

Chair: Sung Su Yun (Yeungnam Univ.), Hyeyoung Kim (Soonchunhyang Univ.)

  • 09:10-09:30

  • Management of Acute Cholecystitis

    Shang Yu Wang (Chang Gung Memorial Hospital, Taiwan)

  • 09:30-09:50

  • Non-Operative Management of Acute Cholecystitis

    Yun Nah Lee (Soonchunhyang Univ.)

  • 09:50-10:10

  • Pancreatic Surgery in Cirrhotic Patients

    Young-Dong Yu (Korea Univ.)

  • 10:10-10:30

  • Perihilar Cholangiocarcinoma in Cirrhotic Patients

    Min-Su Park (Kyung Hee Univ.)

  • 12:20-13:10

  • Luncheon Symposium 10 [Celltrion]

13:40-15:00

KAHBPS Symposium 3
Surgical Liver Resection of HCC in Various Conditions

Chair: Yang-Seok Koh (Chonnam National Univ.), Bong-Wan Kim (Ajou Univ.)

  • 13:40-14:00

  • Management and Prognosis of Ruptured HCC

    Jae Hyun Kwon (Hallym Univ.)

  • 14:00-14:20

  • Overcoming Small Estimated Future Remnant Liver Volume

    Alfred Kow (National Univ. of Singapore, Singapore)

  • 14:20-14:40

  • Large HCC in Surgical Resection Era

    Sang Jin Kim (Korea Univ.)

  • 14:40-15:00

  • Liver Resection in Elderly HCC Patients

    Boram Lee (Seoul National Univ.)

07:30-08:00

KASL Branch EMW 5 [Daegu-Gyeongbuk]

Chair: Byoung Kuk Jang (Keimyung Univ.)

  • 07:30-07:50

  • Is There a Complete Biochemical Response Indicative of Histological Remission in Autoimmune Hepatitis?

    Jeong Eun Song (Daegu Catholic Univ.)

  • 07:50-08:00

  • Discussion

08:00-09:00

Pathology Seminar
Bridging Pathology and Clinical Practice in Liver Disease

Chair: Young Nyun Park (Yonsei Univ.), Xiong Ma (Shanghai Jiao Tong Univ., China)

  • 08:00-08:20

  • Challenges in the Diagnosis and Care of AIH, DILI, and DI-ALH: A Pathologist's Perspective

    Haeryoung Kim (Seoul National Univ.)

  • 08:20-08:40

  • Challenges in the Diagnosis and Care of AIH, DILI, and DI-ALH: A Clinician's Perspective

    Kyung-Ah Kim (Inje Univ.)

  • 08:40-09:00

  • Computational Pathology in Liver Diseases

    Sung Hak Lee (The Catholic Univ. of Korea)

07:30-08:00

KASL Branch EMW 6 [Jeonbuk]

Chair: Eun Young Cho (Wonkwang Univ.)

  • 07:30-07:50

  • Noninvasive Assessment of MASLD and Liver Fibrosis: Clinical Perspectives and Case Reviews

    Chang Hun Lee (Jeonbuk National Univ.)

  • 07:50-08:00

  • Discussion

08:00-09:00

Basic Research 2
Molecular and Cellular Dynamics in Liver Fibrosis and Cancer

Chair: Kyun-Hwan Kim (Sungkyunkwan Univ.), Kang Mo Kim (Univ. of Ulsan)

  • 08:00-08:20

  • Drug Discovery for Liver Fibrosis through Employing Functional Morphometry in Multicellular Hepatic Spheroid (MCHS)

    Haeng Ran Seo (Institut Pasteur Korea)

  • 08:20-08:40

  • Role of Protein Phosphatase in the Development and Treatment of HCC

    Chang-Woo Lee (Sungkyunkwan Univ.)

  • 08:40-09:00

  • Circulating Extracellular Vesicles as a Promising Source of Biomarkers of HCC

    Soon Sun Kim (Ajou Univ.)

13:40-15:00

Special Interest Group 2
Advancing and Discovering Cures for Rare Liver Disease

Chair & Panel: Sook-Hyang Jeong (Seoul National Univ.), Ja Kyung Kim (Yonsei Univ.)

  • 13:40-14:00

  • Emerging Diagnostic and Therapeutic Approaches for Wilson's Disease

    Beom Hee Lee (Univ. of Ulsan)

  • 14:00-14:20

  • Overlap Syndrome: The Difference between Autoimmune Hepatitis and Primary Biliary Cholangitis

    Xiong Ma (Shanghai Jiao Tong Univ., China)

  • 14:20-14:40

  • Second-Line Pharmacotherapies for Hard-to-Treat Autoimmune Hepatitis and Primary Biliary Cholangitis

    Atsumasa Komori (Nagasaki Univ., Japan)

  • 14:40-15:00

  • Panel Discussion
    2 Panelists & Speakers

07:30-08:00

KASL Branch EMW 7 [Busan-Ulsan-Gyeongnam]

Chair: Jeong Heo (Pusan National Univ.), Nae-Yun Heo (Inje Univ.)

  • 07:30-07:40

  • Is the Early Treatment of CHB Reasonable? : Pros

    Yeowool Kang (Dong-A Univ.)

  • 07:40-07:50

  • Is the Early Treatment of CHB Reasonable? : Cons

    Kiyoun Yi (Pusan National Univ.)

  • 07:50-08:00

  • Discussion

09:10-10:30

Clinical Hepatology (*K)

Chair: Joon Hyeok Lee (Sungkyunkwan Univ.), Chang Hyeong Lee (Daegu Catholic Univ.)

  • 09:10-09:30

  • Sarcopenia, Malnutrition, and Frailty in Patients with Liver Cirrhosis

    Tae Hyung Kim (Hallym Univ.)

  • 09:30-09:50

  • Management of Liver Disease in Pregnancy and Pregnancy-Associated Liver Disease

    Sung-Eun Kim (Hallym Univ.)

  • 09:50-10:10

  • Guidance for Managing the Long-Term Side Effects of Chronic Hepatitis B Antivirals

    Jung Hwan Yu (Inha Univ.)

  • 10:10-10:30

  • Management and Rechallenge after Immune-Related Adverse Events of Immune Checkpoint Inhibitors

    Wonseok Kang (Sungkyunkwan Univ.)

  • 12:20-13:10

  • Luncheon Symposium 11

13:40-15:00

Special Interest Group 3
Navigating the Path to Hepatitis B Virus Eradication: Targets and Trials

Chair & Panel: Jin-Wook Kim (Seoul National Univ.), Tatsuya Kanto (National Center for Global Health and Medicine, Japan)

  • 13:40-14:00

  • Experimental in Vitro and in Vivo Models for Hepatitis B Virus Cure Research

    Wenhui Li (Tsinghua Univ., China)

  • 14:00-14:20

  • Treatment Endpoints and Study Design to Cure Hepatitis B Virus

    Sang Hoon Ahn (Yonsei Univ.)

  • 14:20-14:40

  • Promising Results for Curing Hepatitis B Virus: Viral and Immune Targets

    Man-Fung Yuen (The Univ. of Hong Kong, Hong Kong)

  • 14:40-15:00

  • Panel Discussion
    2 Panelists & Speakers

The Liver Week 2021

SECRETARIAT OF THE LIVER WEEK 2024

HB&I, #1711, Hanshin Building, Mapo-daero, Mapo-gu, Seoul, Korea, 04175

Tel: +82-2-373-1005    l    Fax: +82-2-373-1106
E-mail: theliverweek@hbni.co.kr

The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero (MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, Korea, 04185

TEL: +82-2-703-0051    l    Fax: +82-2-703-0071
E-mail: kasl@kams.or.kr